integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
TWLPMPGSSFTOAZ-VVLOTQQHSA-N
CE(15:1)
TWLPMPGSSFTOAZ-VVLOTQQHSA-N
CHEBI:89567
0 Reactome links
1 studies
1
Observed studies
1
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
TWLPMPGSSFTOAZ-VVLOTQQHSA-N
InChI Key
TWLPMPGSSFTOAZ-VVLOTQQHSA-N
IUPAC name
Preferred name
CE(15:1)
INN name
—
Synonym
(1S,2R,5S,10S,11S,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (9E)-pentadec-9-enoate
ChEBI
CHEBI:89567
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
Observed in differential profiles
Mild_vs_Severe